Obafemi Awolowo University

This study is testing if adding a common antimalarial drug, artesunate, to the standard leukemia drug imatinib works better than imatinib alone. It involves 75 patients in Nigeria with chronic myeloid leukemia (CML), including some whose current treatment isn't working well enoug…